Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,310.80
(
-0.16%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
107.30
(
-0.16%
)
Bitcoin
76,942.98
(
-0.60%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 69465

Wednesday, 01/14/2009 6:33:35 PM

Wednesday, January 14, 2009 6:33:35 PM

Post# of 257580
Re: MNTA HSP / Lovenox ANDA’s (follow-up to #msg-33960572)

The modus operandi on HSP’s JPM webcast today was don’t ask, don’t tell. By this I mean that no investors in the audience asked about Lovenox and HSP did not volunteer anything.

Insofar as the vial formulation represents only 1% of Lovenox’s US sales,
I continue to find it odd that HSP has submitted a Lovenox ANDA for the vial formulation only.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today